FDA’s Internal Research Activities Will Get Broad Review By Science Board
Executive Summary
FDA's Science Board is conducting a strategic review of agency research projects as part of an effort to reduce duplication and identify deficient areas
You may also be interested in...
FDA Should Look Through IIRIS To Improve Science, Panel Says; Funding Is Worry
Increasing developments in emerging sciences, such as personalized medicine, could reach roadblocks at FDA where limited resources for specialized personnel and advanced equipment may inhibit research, a report from FDA's Science Board's Subcommittee on Science and Technology shows
FDA Should Look Through IIRIS To Improve Science, Panel Says; Funding Is Worry
Increasing developments in emerging sciences, such as personalized medicine, could reach roadblocks at FDA where limited resources for specialized personnel and advanced equipment may inhibit research, a report from FDA's Science Board's Subcommittee on Science and Technology shows
Janet Woodcock’s Mission: Predict Adverse Events, ID Them After They Happen
FDA's drug safety reforms in response to the Institute of Medicine's report include emphasizing the newly created position of chief medical officer